ATE236975T1 - Haarnadelförmiges ribozym - Google Patents
Haarnadelförmiges ribozymInfo
- Publication number
- ATE236975T1 ATE236975T1 AT93914943T AT93914943T ATE236975T1 AT E236975 T1 ATE236975 T1 AT E236975T1 AT 93914943 T AT93914943 T AT 93914943T AT 93914943 T AT93914943 T AT 93914943T AT E236975 T1 ATE236975 T1 AT E236975T1
- Authority
- AT
- Austria
- Prior art keywords
- polyribonucleotide
- ribozyme
- hairpin
- shaped
- forth
- Prior art date
Links
- 108091092562 ribozyme Proteins 0.000 title abstract 3
- 102000053642 Catalytic RNA Human genes 0.000 title abstract 2
- 108090000994 Catalytic RNA Proteins 0.000 title abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 3
- 102000040430 polynucleotide Human genes 0.000 abstract 3
- 229940124321 AIDS medicine Drugs 0.000 abstract 1
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/122—Hairpin
Landscapes
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17570692 | 1992-07-02 | ||
| JP23691692 | 1992-09-04 | ||
| PCT/JP1993/000907 WO1994001549A1 (fr) | 1992-07-02 | 1993-07-02 | Ribozyme bouclee en epingle a cheveux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE236975T1 true ATE236975T1 (de) | 2003-04-15 |
Family
ID=26496887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93914943T ATE236975T1 (de) | 1992-07-02 | 1993-07-02 | Haarnadelförmiges ribozym |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5631115A (de) |
| EP (1) | EP0653488B1 (de) |
| AT (1) | ATE236975T1 (de) |
| AU (1) | AU672018B2 (de) |
| CA (1) | CA2139411A1 (de) |
| DE (1) | DE69332856D1 (de) |
| NO (1) | NO311258B1 (de) |
| WO (1) | WO1994001549A1 (de) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19532651A1 (de) * | 1995-09-05 | 1997-03-06 | Aloysius Dr Dickgreber | Mittel zur therapeutischen Anwendung bei HIV-Infektionen |
| US5888767A (en) | 1996-11-27 | 1999-03-30 | The Johns Hopkins University School Of Medicine | Method of using a conditionally replicating viral vector to express a gene |
| US5885806A (en) * | 1995-11-28 | 1999-03-23 | The Johns Hopkins University School Of Medicine | Methods to prepare conditionally replicating viral vectors |
| US6274369B1 (en) * | 1996-02-02 | 2001-08-14 | Invitrogen Corporation | Method capable of increasing competency of bacterial cell transformation |
| US8568766B2 (en) | 2000-08-24 | 2013-10-29 | Gattadahalli M. Anantharamaiah | Peptides and peptide mimetics to treat pathologies associated with eye disease |
| AU2001296846B2 (en) | 2000-10-12 | 2007-07-05 | University Of Rochester | Compositions that inhibit proliferation of cancer cells |
| KR20040096554A (ko) | 2002-02-06 | 2004-11-16 | 비코르 테크놀로지스 인코포레이티드 | 경색방지 분자 |
| WO2003093452A2 (en) * | 2002-02-26 | 2003-11-13 | University Of Utah Research Foundation | Variants of nedd4l associated with hypertension and viral budding |
| US20040005546A1 (en) | 2002-02-28 | 2004-01-08 | Oncolytics Biotech Inc. | Use of ribozymes in the detection of adventitious agents |
| CA2374388C (en) | 2002-02-28 | 2005-07-12 | Matthew C. Coffey | The use of ribozymes in the detection of adventitious agents |
| CA2495478A1 (en) | 2002-08-05 | 2004-02-12 | University Of Rochester | Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| US9233120B2 (en) | 2002-11-15 | 2016-01-12 | Jyant Technologies | Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration |
| US8658377B2 (en) | 2002-11-15 | 2014-02-25 | Morehouse School Of Medicine | Detecting cancer with anti-CCL25 and anti-CCR9 antibodies |
| US8512701B2 (en) | 2002-11-15 | 2013-08-20 | Morehouse School Of Medicine | Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration |
| WO2004050674A2 (en) * | 2002-12-04 | 2004-06-17 | Algos Therapeutics, Inc. | Methods and materials for modulating trpm2 |
| US8129124B2 (en) | 2005-02-02 | 2012-03-06 | The Uab Research Foundation | Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists |
| EP3312196B1 (de) | 2005-03-23 | 2019-07-17 | Genmab A/S | Antikörper gegen cd38 zur behandlung von multiplem myelom |
| US7476733B2 (en) | 2005-03-25 | 2009-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease |
| FR2887259B1 (fr) * | 2005-06-21 | 2007-09-14 | Agronomique Inst Nat Rech | CONSTRUCTION D'ADNc D'ALPHAVIRUS DE SALMONIDES |
| CA2625349A1 (en) * | 2005-10-06 | 2007-04-19 | Emthrax, Llc | Methods and compositions relating to anthrax spore glycoproteins as vaccines |
| EP1934348B1 (de) * | 2005-10-11 | 2018-05-02 | Ben-Gurion University Of The Negev Research And Development Authority | Zusammensetzung zum silencing der expression von vdac1 und verwendungen davon |
| EP2392646A1 (de) | 2005-10-14 | 2011-12-07 | MUSC Foundation For Research Development | Targeting von PAX2 zur Induktion der DEFB1-vermittelten Tumorimmunität und Krebstherapie |
| US8080534B2 (en) | 2005-10-14 | 2011-12-20 | Phigenix, Inc | Targeting PAX2 for the treatment of breast cancer |
| CA2664189C (en) | 2006-09-21 | 2017-11-21 | University Of Rochester | Compositions and methods related to protein displacement therapy for myotonic dystrophy |
| DE602007014389D1 (de) | 2006-11-01 | 2011-06-16 | Medical Res And Infrastructure Fund Of The Tel Aviv | Adipozytenspezifische konstrukte und verfahren zur hemmung der expression von blutplättchen-typ-12-lipoxygenase |
| EP2104516B1 (de) | 2006-11-01 | 2015-01-07 | University of Rochester | Verfahren und zusammensetzungen in zusammenhang mit der struktur und funktion von apobec3g |
| CN101600451A (zh) | 2006-12-11 | 2009-12-09 | 犹他大学研究基金会 | 用于治疗病理性血管生成和血管通透性的组合物和方法 |
| US8557767B2 (en) | 2007-08-28 | 2013-10-15 | Uab Research Foundation | Synthetic apolipoprotein E mimicking polypeptides and methods of use |
| AU2008296478B9 (en) | 2007-08-28 | 2015-03-19 | The Uab Research Foundation | Synthetic apolipoprotein E mimicking polypeptides and methods of use |
| CA2706317C (en) | 2007-12-03 | 2017-06-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Doc1 compositions and methods for treating cancer |
| US20090233993A1 (en) * | 2008-03-06 | 2009-09-17 | Burnham Institute For Medical Research | Compositions and methods for inhibiting gsk3 activity and uses thereof |
| EP2288922B1 (de) | 2008-05-08 | 2016-08-17 | University of Utah Research Foundation | Sensorische rezeptoren für chronische müdigkeit und schmerzen und verwendungen dafür |
| EP2370080A1 (de) | 2008-12-02 | 2011-10-05 | University of Utah Research Foundation | Pde1 als zieltherapeutikum bei herzkrankheiten |
| WO2011031974A1 (en) | 2009-09-10 | 2011-03-17 | Southern Research Institute | Acridine analogs in the treatment of gliomas |
| US20110207789A1 (en) | 2010-02-19 | 2011-08-25 | Ye Fang | Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents |
| US20160051629A1 (en) | 2013-04-15 | 2016-02-25 | Yeda Research And Development Co. Ltd. | Inhibition of rip kinases for treating lysosomal storage diseases |
| AU2015298263B2 (en) | 2014-07-31 | 2020-05-14 | Anji Pharmaceuticals, Inc. | ApoE mimetic peptides and higher potency to clear plasma cholesterol |
| US10723794B2 (en) | 2015-03-18 | 2020-07-28 | University Of South Carolina | Anti-CcL8 antibodies and uses thereof |
| JP2019524787A (ja) | 2016-08-03 | 2019-09-05 | エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド | Ｔｌｒ９標的治療薬 |
| US12016314B2 (en) | 2017-09-08 | 2024-06-25 | Ohio State Innovation Foundation | MicroRNA inhibitor therapy in systemic lupus erythematosus |
| IL267614A (en) | 2019-06-24 | 2019-09-26 | Lotem Michal | Nucleic acids to modulate SLAMF6 isoforms |
| US12492245B2 (en) | 2021-09-21 | 2025-12-09 | University Of South Carolina | Anti-CCL8 antibodies and treatment of lung injury by CCL8 inhibition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE115999T1 (de) * | 1987-12-15 | 1995-01-15 | Gene Shears Pty Ltd | Ribozyme. |
| CA1340323C (en) * | 1988-09-20 | 1999-01-19 | Arnold E. Hampel | Rna catalyst for cleaving specific rna sequences |
-
1993
- 1993-07-02 DE DE69332856T patent/DE69332856D1/de not_active Expired - Lifetime
- 1993-07-02 AT AT93914943T patent/ATE236975T1/de not_active IP Right Cessation
- 1993-07-02 US US08/367,175 patent/US5631115A/en not_active Expired - Fee Related
- 1993-07-02 WO PCT/JP1993/000907 patent/WO1994001549A1/ja not_active Ceased
- 1993-07-02 EP EP93914943A patent/EP0653488B1/de not_active Expired - Lifetime
- 1993-07-02 AU AU45130/93A patent/AU672018B2/en not_active Ceased
- 1993-07-02 CA CA002139411A patent/CA2139411A1/en not_active Abandoned
-
1994
- 1994-12-30 NO NO19945103A patent/NO311258B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU672018B2 (en) | 1996-09-19 |
| US5631115A (en) | 1997-05-20 |
| NO945103D0 (no) | 1994-12-30 |
| EP0653488B1 (de) | 2003-04-09 |
| EP0653488A1 (de) | 1995-05-17 |
| NO945103L (no) | 1995-03-02 |
| AU4513093A (en) | 1994-01-31 |
| DE69332856D1 (de) | 2003-05-15 |
| WO1994001549A1 (fr) | 1994-01-20 |
| EP0653488A4 (de) | 1997-01-15 |
| CA2139411A1 (en) | 1994-01-20 |
| NO311258B1 (no) | 2001-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE236975T1 (de) | Haarnadelförmiges ribozym | |
| TR200001892T2 (tr) | Monomer cinsi ensülin analogları ve bunların kullanımı. | |
| ES2130428T3 (es) | Cristales de insulina asp-b28. | |
| DK1295600T3 (da) | Lægemiddel baseret på gestagener til dermal anvendelse indeholdende ascorbinsyre og/eller salte deraf | |
| PT1143937E (pt) | O e declinio rapido das concentracoes eficazes de droga no plasma formulacoes de libertacao controlada com um arranque rapid | |
| CY1111153T1 (el) | Μορφη οσμοτικης δοσολογιας παρατεταμενης απελευθερωσης | |
| EA200200616A1 (ru) | Химические производные и их применение в качестве антителомеразного агента | |
| ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| ES2124861T3 (es) | Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa. | |
| DE50009838D1 (de) | Humanes antibiotisches protein | |
| DE60125232D1 (de) | Kleines säurelösliches sporenprotein und seine verwendungen | |
| IT1317930B1 (it) | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione | |
| ATE28188T1 (de) | Antikonvulsive mittel. | |
| EA199901061A1 (ru) | Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии | |
| CY1106702T1 (el) | Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων | |
| ATE87905T1 (de) | Anticonvulsive agenzien. | |
| CY1106235T1 (el) | Χρηση της l-καρνιτινης ως σταθepοποιητικου παραγοντα πρωτεϊνων | |
| FR2818147B1 (fr) | Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine | |
| ES2053834T3 (es) | Un metodo para la preparacion de una sustancia terapeutica. | |
| ES2185147T3 (es) | Nuevos usos medicos del orosomucoide. | |
| DE69008282D1 (de) | Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen. | |
| ES1032126Y (es) | Juego esterilizable para la autoinyeccion de drogas. | |
| IT1298394B1 (it) | Siringa ipodermica monouso. | |
| FR2764506B1 (fr) | Composition therapeutique ou hygienique a liberation controlee et prolongee de principe(s) actif(s), notamment a usage ophtalmique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |